Blue Owl Capital Holdings »

Silexion Therapeutics Corp shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Silexion Therapeutics Corp shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Silexion Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Silexion Therapeutics Corp held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silexion Therapeutics Corp by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $396 13k 0.03

More positions owned by Blue Owl Capital Holdings

Nuveen Churchill Direct Lend Com Shs (NCDL)
Klaviyo Com Ser A (KVYO)
Tourmaline Bio (TRML)
Pliant Therapeutics (PLRX)
Cullinan Oncology (CGEM)
Owl Rock Capital Corporation (OBDC)
Larimar Therapeutics (LRMR)
Proshares Tr Ultrapro Qqq (TQQQ)
Engene Holdings (ENGN)
Evercommerce (EVCM)
Acelyrin (SLRN)
Conduent Incorporate (CNDT)
Repare Therapeutics Ord (RPTX)
Context Therapeutics (CNTX)
Ultragenyx Pharmaceutical (RARE)

View all positions for Blue Owl Capital Holdings

Top funds holding Silexion Therapeutics Corp

Polar Securities
Hartree Partners
Security Benefit Life Insurance
Highbridge Capital Management
Periscope Capital
Kepos Capital
Jane Street
Context Capital Management
Picton Mahoney Asset Management
Tenor Capital Management
Gabelli Securities
Susquehanna International
DuPont Capital Management Corporation
Gabelli Funds
Citadel Advisors

View all funds holding Silexion Therapeutics Corp